Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asante Gold Corp stock logo
ASE
Asante Gold
C$0.00
C$0.05
C$0.18
N/AN/AN/A1,000 shs
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.16
+4.5%
$1.22
$0.84
$2.03
$44.21M0.99119,028 shs97,410 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
PMA
PetroMaroc
C$0.04
+16.7%
C$0.03
C$0.03
C$0.17
C$5.45MN/A476,876 shs43,000 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asante Gold Corp stock logo
ASE
Asante Gold
0.00%0.00%0.00%0.00%0.00%
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.00%-3.48%-7.50%+2.78%-32.32%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
PMA
PetroMaroc
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.6496 of 5 stars
3.50.00.00.00.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
PMA
PetroMaroc
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00503.71% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
PMA
PetroMaroc
N/AN/AN/AN/A

Current Analyst Ratings

Latest PMA, ASE, BOLT, and CZX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.61N/AN/A$2.97 per share0.39
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
PMA
PetroMaroc
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
PMA
PetroMaroc
N/AN/A0.00N/AN/AN/AN/AN/A

Latest PMA, ASE, BOLT, and CZX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
PMA
PetroMaroc
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
PMA
PetroMaroc
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Asante Gold Corp stock logo
ASE
Asante Gold
N/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
PMA
PetroMaroc
N/A

Insider Ownership

CompanyInsider Ownership
Asante Gold Corp stock logo
ASE
Asante Gold
N/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
PMA
PetroMaroc
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Asante Gold Corp stock logo
ASE
Asante Gold
N/AN/AN/ANot Optionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
PMA
PetroMaroc
N/A155.83 millionN/ANot Optionable

PMA, ASE, BOLT, and CZX Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Asante Gold logo

Asante Gold

CNSX:ASE
Asante Gold Corporation, a mineral exploration company, engages in the acquisition, exploration, and development of mineral resource properties in the Republic of Ghana. It holds 100% interest in the Fahiakoba concession situated in the Ashanti and Central regions in the Republic of Ghana; and 90% interest in the Bibiani gold mine located in the western region of Ghana. The company also has an option to acquire a 100% interest in the Betenase permit located in Ghana; 90% interest in the Kubi Mining lease located in southwest Ghana; and 100% interest in the Keyhole Gold project. Asante Gold Corporation was incorporated in 2011 and is based in Vancouver, Canada.
Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.

PetroMaroc

CVE:PMA
PetroMaroc Corporation plc, formerly LONGREACH OIL AND GAS LIMITED, is an exploration stage company. The Company is engaged in the evaluation, acquisition, exploration and development of oil and gas properties in Morocco. The Company is an independent oil and gas company focused on its land position in Morocco. The Company holds approximately 50% operated interest in the Sidi Moktar license area covering approximately 2,680 square kilometers. Its over three blocks, totaling approximately 4,500 square kilometers, are located in the Essaouira Basin in central Morocco. Approximately four fields within Sidi Moktar have produced over 30.5 billion cubic feet of gas from Jurassic-aged reservoirs. The Company's subsidiaries are Longreach Oil and Gas Ventures Limited, Longreach Oil and Gas (Canada) Limited and Longreach Oil and Gas (UK) Ltd.